Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study

Authors: Anna Hayden, Kanna Hayashi, Huiru Dong, Michael-John Milloy, Thomas Kerr, Julio SG Montaner, Evan Wood

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

Illicit drug use is a well-established risk factor for morbidity and mortality. However, few studies have examined the impact of different drug use patterns on mortality among polysubstance using populations. This study aimed to identify drug-specific patterns of mortality among a cohort of polysubstance using persons who inject drugs (PWIDs).

Methods

PWIDs in Vancouver, Canada were prospectively followed between May 1996 and December 2011. Participants were linked to the provincial vital statistics database to ascertain mortality rates and causes of death. We used multivariate Cox proportional hazards regression to investigate the relationships between drug use patterns (daily alcohol use, heroin injection and non-injection use, cocaine injection, amphetamine injection and non-injection use, crack smoking and speedball injecting) and time to all-cause mortality.

Results

2330 individuals were followed for a median of 61 months (inter-quartile range: 33 – 112). In total, 466 (19.1%) individuals died for an incidence density of 3.1 (95% confidence interval [CI]: 2.8 – 3.4) deaths per 100 person-years. In multivariate analyses, after adjusting for HIV infection and other potential confounders, only daily cocaine injection remained independently associated with all-cause mortality (adjusted hazard ratio [AHR] = 1.36, 95% CI: 1.06 – 1.76).

Conclusions

Although heroin injecting is traditionally viewed as carrying the highest risk of mortality, in this setting, only daily cocaine injecting was associated with all-cause mortality. These findings highlight the urgent need to identify novel treatments and harm reduction strategies for cocaine injectors.
Literature
1.
Hulse GK, English DR, Milne E, Holman CD: The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999, 94 (2): 221-229. 10.1046/j.1360-0443.1999.9422216.x.CrossRefPubMed
2.
Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction. 2003, 98 (6): 739-747. 10.1046/j.1360-0443.2003.00376.x.CrossRefPubMed
3.
Stoove MA, Dietze PM, Aitken CK, Jolley D: Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug Alcohol Depend. 2008, 96 (3): 281-285. 10.1016/j.drugalcdep.2008.03.006.CrossRefPubMed
4.
Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, Kirk G, Hall WD: Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011, 113 (2–3): 88-95.CrossRefPubMed
5.
Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J: Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011, 106 (1): 32-51. 10.1111/j.1360-0443.2010.03140.x.CrossRefPubMed
6.
Singleton J, Degenhardt L, Hall W, Zabransky T: Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend. 2009, 105 (1–2): 1-8.CrossRefPubMed
7.
Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR: Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J Urban Health. 2003, 80 (2): 261-273. 10.1093/jurban/jtg029.CrossRefPubMedPubMedCentral
8.
Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M: Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013, 91 (2): 102-123. 10.2471/BLT.12.108282.CrossRefPubMedPubMedCentral
9.
Warner-Smith M, Darke S, Day C: Morbidity associated with non-fatal heroin overdose. Addiction. 2002, 97 (8): 963-967. 10.1046/j.1360-0443.2002.00132.x.CrossRefPubMed
10.
Hickman M, Carnwath Z, Madden P, Farrell M, Rooney C, Ashcroft R, Judd A, Stimson G: Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health. 2003, 80 (2): 274-287. 10.1093/jurban/jtg030.CrossRefPubMedPubMedCentral
11.
Arendt M, Munk-Jorgensen P, Sher L, Jensen SO: Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abuse Treat. 2013, 44 (4): 400-406. 10.1016/j.jsat.2012.09.007.CrossRefPubMed
12.
Tyndall MW, Craib KJ, Currie S, Li K, O’Shaughnessy MV, Schechter MT: Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr. 2001, 28 (4): 351-357. 10.1097/00126334-200112010-00008.CrossRefPubMed
13.
Merrall EL, Bird SM, Hutchinson SJ: Mortality of those who attended drug services in Scotland 1996–2006: record-linkage study. Int J Drug Policy. 2012, 23 (1): 24-32. 10.1016/j.drugpo.2011.05.010.CrossRefPubMedPubMedCentral
14.
Bartu A, Freeman NC, Gawthorne GS, Codde JP, Holman CD: Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction. 2004, 99 (1): 53-60. 10.1111/j.1360-0443.2004.00602.x.CrossRefPubMed
15.
Kaye S, Darke S: Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction. 2004, 99 (10): 1315-1322. 10.1111/j.1360-0443.2004.00875.x.CrossRefPubMed
16.
Barrio G, Molist G, de la Fuente L, Fernandez F, Guitart A, Bravo MJ, Brugal MT: Mortality in a cohort of young primary cocaine users: controlling the effect of the riskiest drug-use behaviors. Addict Behav. 2013, 38 (3): 1601-1604. 10.1016/j.addbeh.2012.10.007.CrossRefPubMed
17.
Dias AC, Araujo MR, Dunn J, Sesso RC, de Castro V, Laranjeira R: Mortality rate among crack/cocaine-dependent patients: a 12-year prospective cohort study conducted in Brazil. J Subst Abuse Treat. 2011, 41 (3): 273-278. 10.1016/j.jsat.2011.03.008.CrossRefPubMed
18.
Maas B, Fairbairn N, Kerr T, Li K, Montaner JS, Wood E: Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007, 13 (2): 432-439. 10.1016/j.healthplace.2006.05.005.CrossRefPubMed
19.
Wood EKT: What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy. 2006, 17 (2): 55-60. 10.1016/j.drugpo.2005.12.007.CrossRef
20.
Tyndall MW, Currie S, Spittal P, Li K, Wood E, O’Shaughnessy MV, Schechter MT: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. Aids. 2003, 17 (6): 887-893. 10.1097/00002030-200304110-00014.CrossRefPubMed
21.
Werb D, Debeck K, Kerr T, Li K, Montaner J, Wood E: Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev. 2010, 29 (3): 271-277. 10.1111/j.1465-3362.2009.00145.x.CrossRefPubMedPubMedCentral
22.
Fairbairn N, Kerr T, Buxton JA, Li K, Montaner JS, Wood E: Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend. 2007, 88 (2–3): 313-316.CrossRefPubMed
23.
Wood E, Montaner JS, Li K, Barney L, Tyndall MW, Kerr T: Rate of methadone use among Aboriginal opioid injection drug users. CMAJ. 2007, 177 (1): 37-40. 10.1503/cmaj.070105.CrossRefPubMedPubMedCentral
24.
Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS: Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998, 280 (6): 547-549. 10.1001/jama.280.6.547.CrossRefPubMed
25.
Milloy MJ, Kerr T, Buxton J, Rhodes T, Krusi A, Guillemi S, Hogg R, Montaner J, Wood E: Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2012, 59 (4): 393-399. 10.1097/QAI.0b013e3182433288.CrossRefPubMedPubMedCentral
26.
Spittal PM, Craib KJ, Wood E, Laliberte N, Li K, Tyndall MW, O’Shaughnessy MV, Schechter MT: Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002, 166 (7): 894-899.PubMedPubMedCentral
27.
Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O’Shaughnessy MV, Schechter MT: Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003, 168 (1): 19-24.PubMedPubMedCentral
28.
Arendt M, Munk-Jorgensen P, Sher L, Jensen SO: Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment. Drug Alcohol Depend. 2011, 114 (2–3): 134-139.PubMed
29.
Fugelstad A, Annell A, Rajs J, Agren G: Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand. 1997, 96 (3): 169-175. 10.1111/j.1600-0447.1997.tb10147.x.CrossRefPubMed
30.
White JM, Irvine RJ: Mechanisms of fatal opioid overdose. Addiction. 1999, 94 (7): 961-972. 10.1046/j.1360-0443.1999.9479612.x.CrossRefPubMed
31.
DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, Wood E: Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ. 2009, 181 (9): 585-589. 10.1503/cmaj.082054.CrossRefPubMedPubMedCentral
32.
Marshall BD, Wood E: Putting risk compensation to rest: reframing the relationship between risk behavior and antiretroviral therapy among injection drug users. AIDS. 2012, 26 (18): 2405-2407. 10.1097/QAD.0b013e3283519b42.CrossRefPubMedPubMedCentral
33.
Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T: Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011, 377 (9775): 1429-1437. 10.1016/S0140-6736(10)62353-7.CrossRefPubMed
34.
Kerr T, Tyndall M, Li K, Montaner J, Wood E: Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005, 366 (9482): 316-318. 10.1016/S0140-6736(05)66475-6.CrossRefPubMed
35.
Wood E, Tyndall MW, Montaner JS, Kerr T: Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006, 175 (11): 1399-1404. 10.1503/cmaj.060863.CrossRefPubMedPubMedCentral
36.
Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JS, Kerr T: Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006, 354 (23): 2512-2514. 10.1056/NEJMc052939.CrossRefPubMed
37.
Debeck KKT, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E: Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011, 113 (2–3): 172-176.CrossRefPubMed
38.
de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M: Pharmacological treatment of cocaine dependence: a systematic review. Addiction. 2002, 97 (8): 931-949. 10.1046/j.1360-0443.2002.00209.x.CrossRefPubMed
39.
Castells X, Casas M, Perez-Mana C, Roncero C, Vidal X, Capella D: Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev. 2010, 2: CD007380
40.
Johnson BA-DN, Wang X, Penberthy K, Javors M, Seneviratne C: Topiramate for the treatment of cocaine addiction a randomized clinical trial. JAMA Psychiatry. 2013, 70 (12): 1338-1346. 10.1001/jamapsychiatry.2013.2295.CrossRefPubMed
41.
Silverman K, Wong CJ, Needham M, Diemer KN, Knealing T, Crone-Todd D, Fingerhood M, Nuzzo P, Kolodner K: A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. J Appl Behav Anal. 2007, 40 (3): 387-410. 10.1901/jaba.2007.40-387.CrossRefPubMedPubMedCentral
42.
Weatherby NR NL, Cesari H, Booth R, McCoy CB, Watters JK, Williams M, Chitwood DD: Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann. 1994, 17 (4): 347-355. 10.1016/0149-7189(94)90035-3.CrossRef
43.
Darke S: Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51 (3): 253-263. 10.1016/S0376-8716(98)00028-3. discussion 267–258CrossRefPubMed
Metadata
Title
The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study
Authors
Anna Hayden
Kanna Hayashi
Huiru Dong
Michael-John Milloy
Thomas Kerr
Julio SG Montaner
Evan Wood
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-1153

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue

Research article

Surveillance of healthcare-associated infections in Piemonte, Italy: results from a second regional prevalence study

Research article

Environmental and cultural correlates of physical activity parenting practices among Latino parents with preschool-aged children: Niños Activos

Research article

A prospective analysis of the effect of neighbourhood and individual social capital on changes in self-rated health of people with chronic illness

Research article

Role of respondents’ education as a mediator and moderator in the association between childhood socio-economic status and later health and wellbeing

Research article

Role of the new rural cooperative medical system in alleviating catastrophic medical payments for hypertension, stroke and coronary heart disease in poor rural areas of China

Study protocol

Designs of two randomized, community-based trials to assess the impact of alternative cookstove installation on respiratory illness among young children and reproductive outcomes in rural Nepal